Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 28 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Shalby Ltd

About the Company - Shalby Ltd

Shalby Ltd. is a Public Limited Listed company incorporated on 30/08/2004 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L85110GJ2004PLC044667 and registration number is 044667. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 647.16 Cr. and Equity Capital is Rs. 108.01 Cr. for the Year ended 31/03/2022.
Hospitals & Medical ServicesShalby Multi-Specialty Hospitals, Ahmedabad Gujarat
NamePosition Held
Dr. Vikram ShahChairman & Managing Director
Mr. Sushobhan DasguptaVice Chairman & Non Exe.Dire
Dr. Ashok BhatiaIndependent Director
CA. Shyamal JoshiIndependent Director
Dr. Umesh MenonIndependent Director
Mr. Tej MalhotraIndependent Director
CA. Sujana ShahIndependent Director
Mr. Vijay KediaIndependent Director

Shalby Ltd. Share Price Update

Share PriceValue
Previous Day₹304.00

Basic Stock Data of Shalby Ltd

Market Cap 3,187 Cr.
Current Price 295
High / Low340/114
Stock P/E39.2
Book Value 89.2
Dividend Yield0.41 %
ROCE10.6 %
ROE7.37 %
Face Value 10.0

Data Source:

Competitors of Shalby Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Metropolis Healthcare Ltd 8,726 Cr. 1,7031,831/1,17169.9 2040.46 %17.4 %15.2 % 2.00
Max India Ltd 899 Cr. 208234/76.0 1230.00 %0.53 %1.81 % 10.0
Thyrocare Technologies Ltd 3,398 Cr. 642695/41555.0 89.22.80 %15.3 %10.6 % 10.0
Max Healthcare Institute Ltd 81,777 Cr. 841910/41277.4 80.70.12 %15.0 %16.1 % 10.0
Narayana Hrudayalaya Ltd 28,395 Cr. 1,3891,445/72336.8 1220.18 %31.6 %33.1 % 10.0
Industry Average24,639.00 Cr956.6047.82123.780.71%15.97%15.36%8.40

Shalby Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Operating Profit31313829282440373426435342
OPM %23%21%20%16%17%15%20%18%17%13%18%22%20%
Other Income2233-244549555
Profit before tax23233119141531292419334331
Tax %26%58%34%44%6%34%34%36%35%28%37%35%38%
Net Profit17102011131020181514212819
EPS in Rs1.560.911.871.001.200.951.861.701.421.291.932.551.77

Shalby Ltd Quarterly Chart

Sakar Healthcare Ltd Profit & Loss

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit6368567179838389122138164
OPM %24%25%19%22%21%18%17%21%17%17%18%
Other Income222710917882224
Profit before tax524336505450575579102126
Tax %28%43%-1%43%27%37%51%23%32%34%
Net Profit3825362939322842546881
EPS in Rs11.177.364.303.403.652.932.553.935.016.277.54
Dividend Payout %0%0%0%0%0%17%20%25%20%19%

Shalby Ltd Profit & Loss Yearly Chart

Shalby Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:16%
3 Years:18%
Compounded Profit Growth
10 Years:%
5 Years:11%
3 Years:35%
Stock Price CAGR
10 Years:%
5 Years:17%
3 Years:42%
1 Year:129%
Return on Equity
10 Years:%
5 Years:5%
3 Years:6%
Last Year:7%

Shalby Ltd Balance Sheet

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital35358787108108108108108107107
Preference Capital001-0-0-0-0-0-0-0
Other Liabilities398576999689105118162212191
Total Liabilities2173515046799619399679971,1941,2811,316
Fixed Assets130175319323650692672660675685686
Other Assets8185102134264233260314488440490
Total Assets2173515046799619399679971,1941,2811,316

Shalby Ltd Reserves and Borrowings Chart

Shalby Ltd Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 60144355791968
Cash from Investing Activity -153-2361-31-51-60-61
Cash from Financing Activity 96222-51-22-3090-50
Net Cash Flow30-63-249-43

Shalby Ltd Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days21294038496471805348
Inventory Days771131191052421,152
Days Payable395462522415606546
Cash Conversion Cycle212940-280-299-339-239-28353654
Working Capital Days35-46-26-34-3577084109108
ROCE %22%13%12%9%7%7%7%10%11%

Shalby Ltd Financial Efficiency Indicators Chart

Shalby Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders55,97452,52453,85455,56255,23354,66654,53752,77552,18152,58050,22549,495

Shalby Ltd Shareholding Pattern Chart

No. of Shalby Ltd Shareholders

Shalby Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Motilal Oswal S&P BSE Healthcare ETF2870.090.01

Shalby Ltd ROCE Trend

Shalby Ltd EPS Trend

Shalby Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)6.315.003.922.552.93
Diluted EPS (Rs.)
Cash EPS (Rs.)10.798.977.335.896.00
Book Value[Excl.RevalReserv]/Share (Rs.)86.4481.1377.2874.0072.20
Book Value[Incl.RevalReserv]/Share (Rs.)86.4481.1377.2874.0072.20
Revenue From Operations / Share (Rs.)75.0164.7239.9045.0842.68
PBDIT / Share (Rs.)14.8412.268.849.188.40
PBIT / Share (Rs.)10.368.295.435.845.33
PBT / Share (Rs.)9.517.335.105.254.67
Net Profit / Share (Rs.)6.315.003.922.552.93
NP After MI And SOA / Share (Rs.)6.315.013.922.552.93
PBDIT Margin (%)19.7818.9322.1520.3519.67
PBIT Margin (%)13.8112.8013.6112.9512.48
PBT Margin (%)12.6711.3212.7711.6510.93
Net Profit Margin (%)8.407.729.835.666.86
NP After MI And SOA Margin (%)8.417.749.835.666.86
Return on Networth / Equity (%)
Return on Capital Employeed (%)10.228.766.417.146.76
Return On Assets (%)5.284.534.252.853.37
Long Term Debt / Equity (X)
Total Debt / Equity (X)
Asset Turnover Ratio (%)0.590.620.420.500.48
Current Ratio (X)2.662.613.322.812.29
Quick Ratio (X)1.711.913.042.622.15
Dividend Payout Ratio (NP) (%)15.9519.9512.7323.590.00
Dividend Payout Ratio (CP) (%)9.3211.136.8110.230.00
Earning Retention Ratio (%)84.0580.0587.2776.410.00
Cash Earning Retention Ratio (%)90.6888.8793.1989.770.00
Interest Coverage Ratio (X)17.4422.4326.3815.5912.69
Interest Coverage Ratio (Post Tax) (X)8.4110.9012.715.345.43
Enterprise Value (Cr.)1573.711305.751041.12520.031378.37
EV / Net Operating Revenue (X)1.961.872.421.072.99
EV / EBITDA (X)9.889.8710.915.2515.20
MarketCap / Net Operating Revenue (X)1.791.802.531.033.03
Retention Ratios (%)84.0480.0487.2676.400.00
Price / BV (X)1.561.441.300.621.79
Price / Net Operating Revenue (X)1.791.802.531.033.03

Shalby Ltd Profitability Ratios (%)

Shalby Ltd Liquidity Ratios

Shalby Ltd Liquidity Ratios (%)

Shalby Ltd Interest Coverage Ratios (X)

Shalby Ltd Valuation Ratios

Fair Value / Intrinsic Value of Shalby Ltd

Fair Value: ₹258.76

The stock is overvalued by 12.29% compared to the current price ₹295

*Investments are subject to market risks

Strength and Weakness of Sakar Healthcare Ltd

  1. The stock has a low average Cash Conversion Cycle of -64.30, which is a positive sign.
  2. The company has higher reserves (518.00 cr) compared to borrowings (0.09 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (481.64 cr) and profit (64.00 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 7.05 and average Dividend Yield of 13.13%.
  2. The stock has a low average ROCE of 9.80%, which may not be favorable.
  3. The stock has a high average Working Capital Days of 35.40, which may not be favorable.

Should I Buy Shalby Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in Shalby Ltd:
    1. Net Profit Margin: 8.40%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 10.22% (Industry Average ROCE: 19.02%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 8.41
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 1.71
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E: 39.4 (Industry average Stock P/E: 52.94)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.15
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Shalby Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE